Aviva
LMAT icon

Aviva’s LeMaitre Vascular LMAT Stock Holding History

Aviva’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$484K Sell
4,433
-1,260
-22% -$120K ﹤0.01% 695
2025
Q4 		$462K Buy
5,693
+479
+9% +$41.2K ﹤0.01% 819
2025
Q3 		$456K Sell
5,214
-432
-8% -$38.6K ﹤0.01% 820
2025
Q2 		$469K Sell
5,646
-1,229
-18% -$103K ﹤0.01% 788
2025
Q1 		$577K Buy
6,875
+778
+13% +$72.4K ﹤0.01% 744
2024
Q4 		$562K Sell
6,097
-1,105
-15% -$106K ﹤0.01% 774
2024
Q3 		$669K Sell
7,202
-659
-8% -$57.1K ﹤0.01% 713
2024
Q2 		$647K Sell
7,861
-2,014
-20% -$148K ﹤0.01% 704
2024
Q1 		$655K Sell
9,875
-1,411
-13% -$87.1K ﹤0.01% 767
2023
Q4 		$641K Buy
11,286
+750
+7% +$39.3K ﹤0.01% 809
2023
Q3 		$574K Sell
10,536
-11,302
-52% -$670K ﹤0.01% 839
2023
Q2 		$1.47M Sell
21,838
-7,006
-24% -$427K 0.01% 722
2023
Q1 		$1.48M Buy
28,844
+6,981
+32% +$339K 0.01% 743
2022
Q4 		$1.01M Sell
21,863
-10,062
-32% -$471K ﹤0.01% 816
2022
Q3 		$1.62M Sell
31,925
-13,594
-30% -$679K 0.01% 743
2022
Q2 		$2.07M Buy
45,519
+11,010
+32% +$492K 0.01% 788
2022
Q1 		$1.6M Sell
34,509
-15,369
-31% -$688K 0.01% 889
2021
Q4 		$2.5M Buy
49,878
+21,435
+75% +$1.11M 0.01% 804
2021
Q3 		$1.51M Buy
+28,443
New +$1.6M 0.01% 890
2021
Q2 		– Sell
-26,012
Closed -$1.27M – 928
2021
Q1 		$1.27M Sell
26,012
-12,740
-33% -$597K 0.01% 765
2020
Q4 		$1.57M Sell
38,752
-31,416
-45% -$1.12M 0.01% 750
2020
Q3 		$2.28M Sell
70,168
-17,773
-20% -$534K 0.01% 702
2020
Q2 		$2.32M Sell
87,941
-67,172
-43% -$1.76M 0.01% 663
2020
Q1 		$3.87M Buy
155,113
+101,007
+187% +$3.12M 0.03% 476
2019
Q4 		$1.95M Buy
+54,106
New +$1.87M 0.01% 744

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Aviva's LMAT Position: Q1 2026 in Review

Aviva reduced its LeMaitre Vascular (LMAT) stake by 22% in Q1 2026, selling an estimated $120K and leaving 4,433 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #695.

Aviva first reported a position in LMAT in Q4 2019 and has held it in 25 quarters since. The position peaked at $3.87M in Q1 2020. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Aviva held 4,433 shares of LeMaitre Vascular worth $484K as of Q1 2026.
  • Aviva sold 1,260 LeMaitre Vascular shares in Q1 2026, an estimated $120K.
  • LeMaitre Vascular made up ﹤0.01% of Aviva's portfolio in Q1 2026, its #695 holding.
  • Aviva first reported a position in LeMaitre Vascular in Q4 2019 and has held it in 25 quarters since.
  • Aviva's LeMaitre Vascular position peaked at $3.87M in Q1 2020.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.